Cabaletta Bio Statistics Share Statistics Cabaletta Bio has 91.47M
shares outstanding. The number of shares has increased by 84.13%
in one year.
Shares Outstanding 91.47M Shares Change (YoY) 84.13% Shares Change (QoQ) 84.02% Owned by Institutions (%) 72.57% Shares Floating 79.01M Failed to Deliver (FTD) Shares 138 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 5.57M, so 6.09% of the outstanding
shares have been sold short.
Short Interest 5.57M Short % of Shares Out 6.09% Short % of Float 6.19% Short Ratio (days to cover) 3.49
Valuation Ratios The PE ratio is -0.97 and the forward
PE ratio is -1.31.
Cabaletta Bio's PEG ratio is
-0.02.
PE Ratio -0.97 Forward PE -1.31 PS Ratio 0 Forward PS 86.3 PB Ratio 0.74 P/FCF Ratio -1.24 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cabaletta Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.15,
with a Debt / Equity ratio of 0.1.
Current Ratio 6.15 Quick Ratio 6.15 Debt / Equity 0.1 Debt / EBITDA -0.12 Debt / FCF -0.17 Interest Coverage -167.3
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-719.65K Employee Count 161 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -44.6% in the
last 52 weeks. The beta is 2.85, so Cabaletta Bio's
price volatility has been higher than the market average.
Beta 2.85 52-Week Price Change -44.6% 50-Day Moving Average 1.71 200-Day Moving Average 1.85 Relative Strength Index (RSI) 69.95 Average Volume (20 Days) 1,736,850
Income Statement
Revenue n/a Gross Profit -4.81M Operating Income -125.14M Net Income -115.86M EBITDA -125.14M EBIT -116.61M Earnings Per Share (EPS) -2.34
Full Income Statement Balance Sheet The company has 163.96M in cash and 15.6M in
debt, giving a net cash position of 148.36M.
Cash & Cash Equivalents 163.96M Total Debt 15.6M Net Cash 148.36M Retained Earnings -349.1M Total Assets 224.5M Working Capital 156.87M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -88.22M
and capital expenditures -2.21M, giving a free cash flow of -90.43M.
Operating Cash Flow -88.22M Capital Expenditures -2.21M Free Cash Flow -90.43M FCF Per Share -1.83
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
